Copyright: ©Author(s) 2026.
World J Methodol. Sep 20, 2026; 16(3): 116058
Published online Sep 20, 2026. doi: 10.5662/wjm.116058
Published online Sep 20, 2026. doi: 10.5662/wjm.116058
Table 3 Characteristics of included studies
| Ref. | Study type | n | Age (years) | Anesthetic agents | Primary outcomes | Follow-up |
| Shahu et al[5], 2024 | RCT | 60 | 42.3 ± 12.1 | Propofol vs etomidate | Seizure duration, hemodynamics | Immediate |
| Zhong et al[14], 2016 | RCT | 90 | 35.2 ± 10.5 | Ketamine (different doses) | Mood, neuropsychological | 1 month |
| Erdogan Kayhan et al[22], 2012 | RCT | 48 | 44.7 ± 15.2 | Ketofol vs propofol | Seizure duration, recovery | Immediate |
| İkiz et al[9], 2021 | RCT | 80 | 46.1 ± 13.7 | Propofol vs propofol + remifentanil | Hemodynamics, seizure duration | Immediate |
| Jindal et al[6], 2020 | RCT | 60 | 38.9 ± 11.3 | Etomidate vs propofol | Motor seizure duration | Immediate |
| Canbek et al[7], 2015 | RCT | 120 | 41.6 ± 14.8 | Propofol vs etomidate vs thiopental | Seizure parameters, recovery | Immediate |
| Mathur et al[10], 2024 | RCT | 100 | 43.2 ± 12.9 | Propofol vs ketofol | Seizure duration, hemodynamics | Immediate |
| Joshi et al[20], 2021 | RCT | 80 | 40.5 ± 13.2 | Ketofol vs etomidate | Seizure duration, recovery | Immediate |
| Brunelin et al[18], 2020 | RCT | 58 | 47.8 ± 15.1 | Propofol + ketamine vs propofol | Clinical response | 6 weeks |
| Guha et al[19], 2022 | RCT | 50 | 39.7 ± 12.6 | Propofol vs ketamine | Efficacy, cognitive function | 2 weeks |
| Bernardoff et al[15], 2026 | Observational | 156 | 52.3 ± 16.4 | Various | Cognitive function | 6 months |
| Hoyer et al[12], 2014 | Observational | 1253 | 54.7 ± 17.2 | Ketamine, etomidate, thiopental, propofol | Seizure parameters | Immediate |
| Krystal et al[16], 2003 | Observational | 89 | 48.2 ± 14.3 | Ketamine vs methohexital | Seizure duration, cognitive | 1 week |
| Kavakbasi et al[24], 2023 | Observational | 124 | 45.9 ± 13.8 | Thiopental vs propofol | Cognitive effects, seizure | 1 month |
| Tufek et al[13], 2014 | Observational | 210 | 47.3 ± 15.6 | Various | Seizure duration, recovery | Immediate |
| Kök Kendirlioğlu et al[25], 2025 | Observational | 78 | 44.1 ± 12.7 | Ketamine + ECT | Treatment resistance | 3 months |
| Lundin et al[17], 2025 | Observational | 892 | 49.6 ± 16.8 | Various | Treatment outcomes | 17 years |
| Yang et al[8], 2025 | Observational | 186 | 41.2 ± 14.5 | Various | Cognitive function | 6 months |
| Gurel et al[28], 2022 | Observational | 120 | 43.8 ± 13.9 | Ketofol, etomidate, propofol, thiopental | Seizure parameters | Immediate |
| Sartorius et al[11], 2021 | Observational | 234 | 52.1 ± 17.3 | S-ketamine + propofol | Seizure quality | Immediate |
| Yoon et al[27], 2023 | Observational | 98 | 46.7 ± 14.2 | Etomidate vs propofol | Clinical response | 3 months |
| Methfessel et al[26], 2023 | Observational | 67 | 51.4 ± 16.1 | Propofol/esketamine vs methohexital | Seizure quality | Immediate |
| Beyazyüz et al[23], 2023 | Observational | 84 | 42.9 ± 13.4 | Propofol vs ketamine-propofol | ECT parameters | Immediate |
- Citation: Tilokani H, Jawed I, Shehzadi A, Ali A, Khan A, Qadir U, Bin Gulzar AH, Zahid R, Khan S, Mal M, Zakeri MA, Aslam H, Siddique MU. Impact of different anesthetic agents (propofol, etomidate, ketamine) on seizure duration and cognitive recovery in electroconvulsive therapy. World J Methodol 2026; 16(3): 116058
- URL: https://www.wjgnet.com/2222-0682/full/v16/i3/116058.htm
- DOI: https://dx.doi.org/10.5662/wjm.116058